GE HealthCare today announced the launch of the new Versana Premier, the latest release within the Versana ultrasound family of ultrasound systems. Versana Premier offers automation and AI-enabled productivity tools to improve workflow and clinical features designed to enhance clinical efficiency and accuracy. The Versana Premier is designed to meet the multi-purpose needs of healthcare professionals across diverse clinical specialties and care areas, including general practice, OBGYN, musculoskeletal (MSK), and cardiology.
Versana Premier allows clinicians to deliver care and accurately make decisions to reach a diagnosis. Powered by VisionBoost Architecture and accompanied by probes, including XDclear technology, display technology and new imaging engine, Versana Premier provides improved image quality with faster speed. Users can also optimize images while scanning with Whizz, which continuously optimizes imaging in real time, and adjust color display with Whizz Color Flow. Other features to support clinicians in clinical decisions include OBGYN imaging tools, like Whizz RenderLive and V-Live 2.0, to capture 3D/4D imaging to clearly follow the baby’s development.
With its enhanced ergonomics, automated tools, service and support, the latest release of Versana Premier offers advanced features for simplified diagnostics and guaranteed time savings. Clinicians can experience up to a 38% faster workflow with Whizz clinical features available on the system. Furthermore, AI-powered Whizz LabeI can automate labeling of the right kidney, gallbladder and liver, and the new Whizz Follicle can assist with volume calculations and measurements.
Versana Premier is the highest-tier ultrasound system in the budget-friendly Versana ultrasound family, powered with smart clinical features and streamlined workflow tools to enhance efficiency and provide optimal care to a wide range of patients every day – all with effortless productivity in mind. Versana Premier is available in key countries around the globe. In the United States, Versana Premier is 510(k) cleared by the U.S. Food and Drug Administration and is currently commercially available, with shipments beginning later this month.
